STOCK TITAN

PROCEPT BioRobotics Corporation - $PRCT STOCK NEWS

Welcome to our dedicated page for PROCEPT BioRobotics Corporation news (Ticker: $PRCT), a resource for investors and traders seeking the latest updates and insights on PROCEPT BioRobotics Corporation stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect PROCEPT BioRobotics Corporation's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of PROCEPT BioRobotics Corporation's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.31%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.56%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.81%
Tags
conferences earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.03%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.51%
Tags
-
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.15%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.2%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.73%
Tags
conferences earnings
PROCEPT BioRobotics Corporation

Nasdaq:PRCT

PRCT Rankings

PRCT Stock Data

3.50B
43.88M
3.62%
91.61%
9.12%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
SAN JOSE

About PRCT

based in silicon valley, procept biorobotics is a privately held surgical robotics company enabling better patient care by developing transformative solutions in urology. with an initial focus on benign prostatic hyperplasia (bph), the company’s first product, the aquabeam system delivering aquablation therapy, is the world’s first commercially available minimally invasive surgical robot providing autonomous tissue removal to safely and effectively treat bph. aquablation therapy offers predictable and reproducible outcomes, independent of prostate anatomy or surgeon experience.